首页> 外文期刊>Materials science & engineering >Self-assembled micellar clusters based on Triton-X-family surfactants for enhanced solubilization, encapsulation, proteins permeability control, and anticancer drug delivery
【24h】

Self-assembled micellar clusters based on Triton-X-family surfactants for enhanced solubilization, encapsulation, proteins permeability control, and anticancer drug delivery

机译:基于Triton-X家族表面活性剂的自组装胶束簇,用于增强溶解,包封,蛋白质渗透控制和抗癌药物递送

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Non-ionic surfactants have raised a considerable interest for solubilization, encapsulation, permeabilization and controlled release of various compounds due to their unique physicochemical properties. Nevertheless, it is still challenging to create convenient self-assembled multifunctional materials with high solubilization and encapsulation capacities by preserving their advanced capabilities to protect loaded cargos without altering their characteristics. In this work, we present an extended concept of micellar clusters (MCs) formation based on partial entrapment and stabilization of chelate ligands by hydrophobic forces found on the non-ionic surfactant micelle interface of the Triton-X family (TX-100/TX-114), followed by subsequent complexation of the preformed structures either by metal ions or a supporting chelator. The formation aspects, inner structure and the role of external factors such as the addition of competitive ligands have been extensively studied. MCs loaded by hydrophobic fluorescent compounds with high encapsulation efficiency demonstrate an excellent optical response in aqueous media without crystallization as well as sufficient increase in solubility of toxic hydrophobic compounds such as bilirubin ( 50 times compared to pure surfactants). Furthermore, Triton-X-based MCs provide a unique feature of selective permeability to hydrophilic ligand-switching proteins such as UnaG and BSA demonstrating bright "turn-on" fluorescence signal either inside the cluster or on its interface via complexation. The proposed strategies allowed us to successfully encapsulate and visualize a newly synthesized, highly hydrophobic anticancer PTR-58-CLB-CAMP peptide drug, while MCs loaded by the drug exhibit a considerable antitumor activity against HeLa cells.
机译:由于其独特的物理化学性质,非离子表面活性剂对各种化合物的溶解,包封,渗透和控释释放的升值相当兴趣。尽管如此,通过保留其先进的能力来保护具有高溶解和封装能力的便捷自组装多功能材料仍然具有挑战性,在不改变其特征的情况下保护装载的固定性,可以保护加载的固定能力。在这项工作中,基于在Triton-X系列的非离子表面活性剂胶束界面上发现的疏水力(TX-100 / TX-)的疏水力,基于螯合配体的部分夹紧和稳定化的胶蛋白簇(MCS)形成的扩展概念114),然后通过金属离子或支撑螯合剂随后络合预制结构。已经广泛研究了形成方面,内部结构和外部因素的作用,例如添加竞争性配体。由具有高封装效率的疏水荧光化合物装载的MCS在水性介质中表现出优异的光学响应而不结晶,并且与诸如纯表面活性剂相比的毒性疏水化合物如胆红素(> 50次)的溶解度充分增加)。此外,基于Triton-X基的MCS提供了亲水性配体切换蛋白的选择性渗透性的独特特征,例如UNAG和BSA,通过络合在簇内或在其界面上证明明亮的“导通”荧光信号。拟议的策略使我们能够成功封装和可视化新合成的高度疏水的抗癌PTR-58-CLB-CAMP肽药物,而药物装载的MCS对HELA细胞具有相当大的抗肿瘤活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号